384 related articles for article (PubMed ID: 15824337)
41. Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double-blind, placebo controlled trial.
Lappin MS; Lawrie FW; Richards TL; Kramer ED
Altern Ther Health Med; 2003; 9(4):38-48. PubMed ID: 12868251
[TBL] [Abstract][Full Text] [Related]
42. Modafinil vs. caffeine: effects on fatigue during sleep deprivation.
Wesensten NJ; Belenky G; Thorne DR; Kautz MA; Balkin TJ
Aviat Space Environ Med; 2004 Jun; 75(6):520-5. PubMed ID: 15198278
[TBL] [Abstract][Full Text] [Related]
43. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
44. Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome.
Randall DC; Cafferty FH; Shneerson JM; Smith IE; Llewelyn MB; File SE
J Psychopharmacol; 2005 Nov; 19(6):647-60. PubMed ID: 16272188
[TBL] [Abstract][Full Text] [Related]
45. Assessing fatigue in multiple sclerosis: Dutch modified fatigue impact scale.
Kos D; Kerckhofs E; Nagels G; D'Hooghe BD; Duquet W; Duportail M; Ketelaer P
Acta Neurol Belg; 2003 Dec; 103(4):185-91. PubMed ID: 15008502
[TBL] [Abstract][Full Text] [Related]
46. Modafinil for the treatment of fatigue in lung cancer: a pilot study.
Spathis A; Dhillan R; Booden D; Forbes K; Vrotsou K; Fife K
Palliat Med; 2009 Jun; 23(4):325-31. PubMed ID: 19270033
[TBL] [Abstract][Full Text] [Related]
47. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial.
Mendonça DA; Menezes K; Jog MS
Mov Disord; 2007 Oct; 22(14):2070-6. PubMed ID: 17674415
[TBL] [Abstract][Full Text] [Related]
48. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
[TBL] [Abstract][Full Text] [Related]
49. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
Nourbakhsh B; Revirajan N; Waubant E
Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
[TBL] [Abstract][Full Text] [Related]
50. A longitudinal study on effects of a six-week course for energy conservation for multiple sclerosis patients.
Sauter C; Zebenholzer K; Hisakawa J; Zeitlhofer J; Vass K
Mult Scler; 2008 May; 14(4):500-5. PubMed ID: 18208883
[TBL] [Abstract][Full Text] [Related]
51. Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial.
Lundorff LE; Jønsson BH; Sjøgren P
Palliat Med; 2009 Dec; 23(8):731-8. PubMed ID: 19648224
[TBL] [Abstract][Full Text] [Related]
52. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
53. Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
Bruera E; El Osta B; Valero V; Driver LC; Pei BL; Shen L; Poulter VA; Palmer JL
J Clin Oncol; 2007 Aug; 25(23):3475-81. PubMed ID: 17687152
[TBL] [Abstract][Full Text] [Related]
54. A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer.
Auret KA; Schug SA; Bremner AP; Bulsara M
J Pain Symptom Manage; 2009 Apr; 37(4):613-21. PubMed ID: 18790598
[TBL] [Abstract][Full Text] [Related]
55. Cognitive performance following modafinil versus placebo in sleep-deprived emergency physicians: a double-blind randomized crossover study.
Gill M; Haerich P; Westcott K; Godenick KL; Tucker JA
Acad Emerg Med; 2006 Feb; 13(2):158-65. PubMed ID: 16436796
[TBL] [Abstract][Full Text] [Related]
56. A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis.
Wingerchuk DM; Benarroch EE; O'Brien PC; Keegan BM; Lucchinetti CF; Noseworthy JH; Weinshenker BG; Rodriguez M
Neurology; 2005 Apr; 64(7):1267-9. PubMed ID: 15824361
[TBL] [Abstract][Full Text] [Related]
57. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial.
Kerr CW; Drake J; Milch RA; Brazeau DA; Skretny JA; Brazeau GA; Donnelly JP
J Pain Symptom Manage; 2012 Jan; 43(1):68-77. PubMed ID: 22208450
[TBL] [Abstract][Full Text] [Related]
58. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
Shearer J; Darke S; Rodgers C; Slade T; van Beek I; Lewis J; Brady D; McKetin R; Mattick RP; Wodak A
Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
[TBL] [Abstract][Full Text] [Related]
59. Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants.
Lam JY; Freeman MK; Cates ME
Ann Pharmacother; 2007 Jun; 41(6):1005-12. PubMed ID: 17519297
[TBL] [Abstract][Full Text] [Related]
60. Does short-term treatment with modafinil affect blood pressure in patients with obstructive sleep apnea?
Heitmann J; Cassel W; Grote L; Bickel U; Hartlaub U; Penzel T; Peter JH
Clin Pharmacol Ther; 1999 Mar; 65(3):328-35. PubMed ID: 10096265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
